Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07440485

Aspergillus Infection in Patients Admitted to Hematology Ward

A Prospective Study on the Incidence of Invasive Aspergillus Infections in Hematology Patients: the Utility of Nasal Swab Screening and Environmental Sampling (AspHem)

Status
Recruiting
Phase
Study type
Observational
Enrollment
193 (estimated)
Sponsor
Fondazione IRCCS Policlinico San Matteo di Pavia · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Aspergillus is a filamentous mould ubiquitous in the environment and the concentration of its spores in the air varies according to weather conditions and seasons. In this regard, efforts are often made to limit its diffusion in wards where fragile patients are housed (e.g., ICU, Haematology, Oncology, etc.). Indeed, in these patients, Aspergillus infections can present as pulmonary aspergillosis, invasive rhinosinusitis or angio-invasive aspergillosis with significantly high rates of morbidity and mortality, while it rarely causes disease in healthy immunocompetent subjects. Previous studies have established the correlation between nasal carriage of microorganisms and the development of an invasive infectious disease; however, those studies mainly focused on Staphylococci and Candida species. The main target of this study is to investigate the spread of Aspergillus within a hospital ward and analyse the correlation between nosocomial infection and symptom severity in a cohort of frail population.

Conditions

Timeline

Start date
2024-02-14
Primary completion
2026-03-14
Completion
2026-03-14
First posted
2026-02-27
Last updated
2026-02-27

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT07440485. Inclusion in this directory is not an endorsement.

Aspergillus Infection in Patients Admitted to Hematology Ward (NCT07440485) · Clinical Trials Directory